![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 5 of 5. This is the beginning of the thread.
Posted by becksA on October 28, 2004, at 8:03:11
Was reading some posts earlier about this drug...is it in a relatively new class of drugs? I first thought it was the "new" neurontin...a GABA drug. Neurontin did NOTHING for my anxiety so I wasn't looking forward to it at all, but then I was reading it's more like a benzo? Can somebody tell me a bit more about this drug, and when it's scheduled for release?
Posted by jaby on October 28, 2004, at 9:39:15
In reply to Lyrica/Pregablin (sp?), posted by becksA on October 28, 2004, at 8:03:11
Yes, it's the "new neurontin". It has been given an approvable (but not approved) status by the FDA. This means Pfizer likely has to submit more info to them. I think they (and I) are hoping for a Q1 2005 release.
Posted by becksA on October 28, 2004, at 10:22:28
In reply to Re: Lyrica/Pregablin (sp?), posted by jaby on October 28, 2004, at 9:39:15
How is it going to be different from Neurontin?
Posted by Glydin on October 28, 2004, at 11:43:24
In reply to Re: Lyrica/Pregablin (sp?), posted by becksA on October 28, 2004, at 10:22:28
A quote:
"Pfizer received a non-approvable letter for Lyrica for the treatment of generalized anxiety disorder."
Their prize Neurotonin is losing patent status and like many companies, they are tweaking a formulation to have a patented product. At this time, if things go as they are going, using this med for anything other than neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and as adjunctive therapy in the treatment of partial seizures in adults would be off label useage - doesn't mean that's a bad thing or that it isn't a good med for anxiety disorders - but it does mean a problematic situation for some of us to obtain and/or have cost coverage to a med that most likely will be quite costly.
I'm slightly interested myself, even though my current med is working well and I'm not sure I really want to change to another drug class with potentially higher long term risks, but I am somewhat interested.
Time will tell how this plays out with the US FDA.
Posted by Glydin on October 28, 2004, at 11:47:03
In reply to Re: Lyrica/Pregablin (sp?), posted by Glydin on October 28, 2004, at 11:43:24
> Their prize Neurotonin is losing patent status and like many companies, they are tweaking a formulation to have a patented product.
That should be has "has lost their patent status", as I believe it has already occurred.
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.